Providing adequate rheumatology health services to patients during the COVID-19 pandemic is essential. Some patients with rheumatological diseases may be among the high-risk population for COVID-19 outcomes, and this may impact the risk and benefit considerations for their ongoing treatments. This article sheds light on the frequently asked questions (FAQs) answered by standard international guidelines to help rheumatologists plan a course of action in managing rheumatology cases amid the COVID-19 pandemic.
What factors should rheumatologists consider when treating rheumatic condition patients? Rheumatologists must consider: Probable impact of immune-modulating therapies on outcomes for COVID-19-infected patients Impact on a patient’s rheumatic disease-related outcome when changing or interrupting their treatment Patient access to treatment. Are patients with rheumatic conditions at…
